Advertisement
GVA vs TVTX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVA is a StrongBuy and TVTX is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GVA’s FA Score shows that 1 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).
- GVA’s FA Score: 1 green, 4 red.
- TVTX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GVA’s TA Score shows that 4 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).
- GVA’s TA Score: 4 bullish, 5 bearish.
- TVTX’s TA Score: 4 bullish, 6 bearish.
Price Growth
GVA (@Engineering & Construction) experienced а +2.23% price change this week, while TVTX (@Biotechnology) price change was -1.29% for the same time period.
The average weekly price growth across all stocks in the @Engineering & Construction industry was +0.60%. For the same industry, the average monthly price growth was +3.90%, and the average quarterly price growth was +14.30%.
The average weekly price growth across all stocks in the @Biotechnology industry was +3.97%. For the same industry, the average monthly price growth was +34.81%, and the average quarterly price growth was +16.51%.
Reported Earning Dates
GVA is expected to report earnings on Jul 24, 2025.
TVTX is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Engineering & Construction (+0.60% weekly)Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.
@Biotechnology (+3.97% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| GVA | TVTX | GVA / TVTX | |
| Capitalization | 3.99B | 1.29B | 310% |
| EBITDA | 351M | -168.21M | -209% |
| Gain YTD | 4.171 | -16.820 | -25% |
| P/E Ratio | 35.77 | N/A | - |
| Revenue | 4.04B | 274M | 1,473% |
| Total Cash | 574M | 322M | 178% |
| Total Debt | 839M | 400M | 210% |
GVA | TVTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 11 | 100 | |
SMR RATING 1..100 | 60 | 100 | |
PRICE GROWTH RATING 1..100 | 45 | 60 | |
P/E GROWTH RATING 1..100 | 95 | 41 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TVTX's Valuation (87) in the Biotechnology industry is in the same range as GVA (100) in the Engineering And Construction industry. This means that TVTX’s stock grew similarly to GVA’s over the last 12 months.
GVA's Profit vs Risk Rating (11) in the Engineering And Construction industry is significantly better than the same rating for TVTX (100) in the Biotechnology industry. This means that GVA’s stock grew significantly faster than TVTX’s over the last 12 months.
GVA's SMR Rating (60) in the Engineering And Construction industry is somewhat better than the same rating for TVTX (100) in the Biotechnology industry. This means that GVA’s stock grew somewhat faster than TVTX’s over the last 12 months.
GVA's Price Growth Rating (45) in the Engineering And Construction industry is in the same range as TVTX (60) in the Biotechnology industry. This means that GVA’s stock grew similarly to TVTX’s over the last 12 months.
TVTX's P/E Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for GVA (95) in the Engineering And Construction industry. This means that TVTX’s stock grew somewhat faster than GVA’s over the last 12 months.
| GVA | TVTX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 57% | 1 day ago 82% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 58% | 7 days ago 89% |
| MACD ODDS (%) | 1 day ago 53% | 1 day ago 76% |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 81% |
| Advances ODDS (%) | 19 days ago 70% | N/A |
| Declines ODDS (%) | 12 days ago 58% | 20 days ago 79% |
| BollingerBands ODDS (%) | 1 day ago 67% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 83% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SPPP | 11.50 | 0.19 | +1.68% |
| Sprott Physical Platinum and Palladium Trust | |||
| FV | 57.99 | 0.76 | +1.33% |
| First Trust Dorsey Wright Focus 5 ETF | |||
| DFAW | 65.64 | 0.58 | +0.89% |
| Dimensional World Equity ETF | |||
| BIS | 18.17 | 0.12 | +0.66% |
| ProShares UltraShort Nasdaq Biotech | |||
| EIDO | 16.89 | -0.29 | -1.69% |
| iShares MSCI Indonesia ETF | |||
GVA and
Correlation & Price change
A.I.dvisor indicates that over the last year, GVA has been closely correlated with EME. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if GVA jumps, then EME could also see price increases.
| Ticker / NAME | Correlation To GVA | 1D Price Change % | ||
|---|---|---|---|---|
| GVA | 100% | +2.45% | ||
| EME - GVA | 73% Closely correlated | +1.97% | ||
| MTZ - GVA | 72% Closely correlated | +1.61% | ||
| FIX - GVA | 70% Closely correlated | +0.59% | ||
| STRL - GVA | 70% Closely correlated | +2.08% | ||
| PRIM - GVA | 69% Closely correlated | +3.01% | ||
More | ||||